Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS
· Delayed Price · Currency is USD
0.2500
+0.0400 (19.05%)
Apr 17, 2025, 2:30 PM EDT
Virpax Pharmaceuticals Employees
Virpax Pharmaceuticals had 2 employees as of December 31, 2024. The number of employees decreased by 5 or -71.43% compared to the previous year.
Employees
2
Change (1Y)
-5
Growth (1Y)
-71.43%
Revenue / Employee
n/a
Profits / Employee
-$6,033,613
Market Cap
272.00K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
Glass House Brands | 374 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Longduoduo Company | 49 |
Virpax Pharmaceuticals News
- 4 weeks ago - Virpax Pharmaceuticals to conduct reverse stock split - Seeking Alpha
- 4 weeks ago - Virpax Pharmaceuticals Announces Reverse Stock Split - Business Wire
- 4 weeks ago - Virpax Receives Positive Probudur™ Results for Dose Range Study Moves Towards Next Steps in IND - Business Wire
- 6 weeks ago - Virpax Looking to Use MET to Develop Intranasal COVID Vaccine - Business Wire
- 6 weeks ago - Virpax's NES100 to be Presented at The Society of Toxicology by NCATS - Business Wire
- 7 weeks ago - Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology - Business Wire
- 2 months ago - Penny Stock Virpax Pharmaceuticals Surges On US Army-Performed Preclinical Study For Pain Candidate - Benzinga
- 2 months ago - Virpax Confirms Positive Results with US Army with Probudur™ for Combat Care Study - Business Wire